共 50 条
- [1] Need for additional trials of primary prophylaxis in patients with high-risk antiphospholipid antibody profiles: comment on the article by Erkan et al ARTHRITIS AND RHEUMATISM, 2008, 58 (02): : 635 - 636
- [2] Intravenous immunoglobulin and antiphospholipid syndrome: comment on the article by Erkan et al - Reply ARTHRITIS AND RHEUMATISM, 2004, 50 (08): : 2711 - 2713
- [3] Thromboembolic events after fetal loss in patients with antiphospholipid syndrome: comment on the article by Erkan et al - Reply ARTHRITIS AND RHEUMATISM, 2002, 46 (04): : 1127 - 1127
- [4] Thromboembolic events after fetal loss in patients with antiphospholipid syndrome: comment on the article by Erkan et al ARTHRITIS AND RHEUMATISM, 2002, 46 (04): : 1126 - 1127
- [5] Antiphospholipid antibody profiling: association with the clinical phenotype of antiphospholipid syndrome? Comment on the article by Otomo et al Reply ARTHRITIS AND RHEUMATISM, 2012, 64 (08): : 2808 - 2809
- [6] Antiphospholipid syndrome nephropathy in antiphospholipid antibody-positive patients with systemic lupus erythematosus: comment on the article by Tektonidou et al Reply ARTHRITIS AND RHEUMATISM, 2005, 52 (03): : 989 - 990
- [7] Antiphospholipid syndrome nephropathy in antiphospholipid antibody-positive patients with systemic lupus erythematosus: comment on the article by Tektonidou et al ARTHRITIS AND RHEUMATISM, 2005, 52 (03): : 988 - 989